Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| BELLEVUE GROUP AG | 11-10-2023 | 09-30-2023 | 196 | 6,206,911,612 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| ARGENX SE | SPONSORED ADR | 1 | $448,135,494 | 911,530 | 0.01 | 0.01 | -11,754 | -1.27 | 09-30-2023 |
| IONIS PHARMACEUTICALS INC | COM | 2 | $418,840,632 | 9,233,700 | 0.01 | 0.01 | -146,600 | -1.56 | 09-30-2023 |
| VERTEX PHARMACEUTICALS INC | COM | 3 | $348,691,069 | 1,002,735 | 0.01 | 0.01 | -94,431 | -8.61 | 09-30-2023 |
| NEUROCRINE BIOSCIENCES INC | COM | 4 | $290,649,375 | 2,583,550 | 0.00 | 0.00 | -29,250 | -1.12 | 09-30-2023 |
